Mednet Logo

How would you treat a patient with Gleason 8 or 9 prostate cancer, pretreatment PSA 15-24, with retroperitoneal adenopathy?

Is there a role of EBRT to the prostate with extended fields to cover the retroperitoneal nodes plus ADT (definitive therapy) or would you treat as castrate sensitive metastatic disease without biopsy confirmation?
4 Answers
Mednet Member
Mednet MemberInvited Expert
Radiation Oncology · UC San Diego
Answered on

I would offer a similar approach to that described nicely by @Dr. First Last and @Dr. First Last: definitive RT+ADT+abiraterone, with SIB to the grossly positive nodes. My caveats and additions are:

  1. I start with a frank discussion with the patient re: evidence for various scenarios and general prog...

Join for free or sign in to see the full answer

Mednet Member
Mednet MemberInvited Expert
Radiation Oncology · Varian Medical Systems/Allegheny health network
Answered on

Patient meets STAMPEDE criteria (about 9% with non regional nodal Mets) and optimal ADT with prostate only RT is also an option especially if nodal burden is to the entire paraaortic region.

Join for free or sign in to see the full answer

Mednet Member
Mednet MemberInvited Expert
Medical Oncology · University of Minnesota–Masonic Cancer Center
Answered on

I would typically use a curative-intent paradigm with ADT + Abiraterone, plus prostate-directed radiotherapy with a radiotherapy boost (if possible) to the pelvic and RP nodes. If PSA remains undetectable after 2 years of systemic therapy, I would consider stopping the ADT + Abi and watching careful...

Join for free or sign in to see the full answer

Mednet Member
Mednet Member
Radiation Oncology · Texas Oncology Arlington South
Answered on

I don’t see the logic in treating only the prostate when u have similar disease in the node. If u radiate, radiate all gross disease area if it can be encompassed in a reasonable volume. With the same dose to gross disease as prostrate, do ADT and arbiter one for 2 to 3 yrs and then follow and go ba...

Join for free or sign in to see the full answer